Delphinus Medical Technologies, Inc. — Form D

Delphinus Medical Technologies, Inc. of NOVI, MI, a company, filed a Form D exempt-offering notice with the SEC on 2024-04-05. The offering totals $15.0M, of which $5.3M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (40)

Showing 25 of 40 people.

NameRoleLocation
Paul McCreadieDirectorANN ARBOR, MI
Neb DuricExecutive OfficerNOVI, MI
Shawn O'BrienExecutive OfficerNOVI, MI
Heather RoneExecutive OfficerNOVI, MI
Olivier RoyExecutive OfficerNOVI, MI
Michael GrossDirectorAnn Arbor, MI
Hugo BraunDirectorNOVI, MI
John NeisDirectorNOVI, MI
Michael FultonDirectorNOVI, MI
Ronald HoDirectorNOVI, MI
Rachel BremDirectorNOVI, MI
Scott WhiteDirectorChampaign, IL
Scott WhiteExecutive OfficerChampaign, IL
Mark ForchetteDirectorNOVI, MI
Mark ForchetteExecutive OfficerNOVI, MI
Elise BermanExecutive OfficerNOVI, MI
Michael EmeryExecutive OfficerNOVI, MI
John J NeisDirectorSarasota, FL
Paul J McCreadieDirectorMenlo Park, CA
Michael J FultonDirectorSt. Louis Park, MN
Debra SaundersExecutive OfficerNovi, MI
Francis DobschaExecutive OfficerNovi, MI
Michael J GrossDirectorPlymouth, MI
Hugo J BraunDirectorPlymouth, MI
Chris J SandersExecutive OfficerPlymouth, MI

Other filings by this issuer (8)

FiledFormOfferingSold
2025-04-03D/A$27.6M$27.6M
2024-11-26D/A$20.4M$20.4M
2023-06-30D$8.0M$5.0M
2022-09-13D$30.4M$30.4M
2017-04-20D$25.0M$8.2M
2015-09-11D$45.0M$39.5M
2010-10-12D/A$9.6M$7.2M
2010-05-21D$8.0M$6.0M

More